{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34335830", "DateRevised": {"Year": "2021", "Month": "08", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "19"}], "Language": ["eng"], "ELocationID": ["5965061", "10.1155/2021/5965061"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Phytochemical Analysis and Evaluation of Biological Activity of <i>Lawsonia inermis</i> Seeds Related to Alzheimer's Disease.", "Pagination": {"StartPage": "5965061", "MedlinePgn": "5965061"}, "Abstract": {"AbstractText": ["Using <i>Lawsonia inermis</i> L. (henna) seeds has been frequently recommended for the improvement of memory in Iranian Traditional Medicine (ITM). In this respect, different fractions of the plant were prepared and evaluated for their <i>in vitro</i> biological assays related to Alzheimer's disease (AD), including acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity as well as metal chelating ability and DPPH antioxidant activity. The dichloromethane and ethyl acetate fractions were able to inhibit the BChE selectively with IC<sub>50</sub> values of 113.47 and 124.90\u2009<i>\u03bc</i>g/mL, respectively, compared with donepezil as the reference drug (IC<sub>50</sub>\u2009=\u20091.52\u2009<i>\u03bc</i>g/mL). However, all fractions were inactive toward AChE. Phytochemical analysis of the dichloromethane fraction indicated the presence of <i>\u03b2</i>-sitosterol (<b>1</b>), 3-<i>O-\u03b2-</i>acetyloleanolic acid (<b>2</b>), 3-<i>O</i>-(<i>Z</i>)-coumaroyl oleanolic acid (<b>3</b>), betulinic acid (<b>4</b>), and oleanolic acid (<b>5</b>). The inhibitory activity of isolated compounds was also evaluated toward AChE and BChE. Among them, compounds <b>2</b> and <b>5</b> showed potent inhibitory activity toward BChE with IC<sub>50</sub> values of 77.13 and 72.20\u2009<i>\u03bc</i>M, respectively. However, all compounds were inactive toward AChE. Moreover, molecular docking study confirmed desired interactions between those compounds and the BChE active site. The ability of fractions and compounds to chelate biometals (Cu<sup>2+</sup>, Fe<sup>2+</sup>, and Zn<sup>2+</sup>) was also investigated. Finally, DPPH antioxidant assay revealed that the ethyl acetate (IC<sub>50</sub>\u2009=\u20093.08\u2009<i>\u03bc</i>g/mL) and methanol (IC<sub>50</sub>\u2009=\u20093.64\u2009<i>\u03bc</i>g/mL) fractions possessed excellent antioxidant activity in comparison to BHA as the positive control (IC<sub>50</sub>\u2009=\u20093.79\u2009<i>\u03bc</i>g/mL)."], "CopyrightInformation": "Copyright \u00a9 2021 Majid Balaei-Kahnamoei et al."}, "AuthorList": [{"Identifier": ["0000-0003-4401-8774"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Balaei-Kahnamoei", "ForeName": "Majid", "Initials": "M"}, {"Identifier": ["0000-0002-9046-8058"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": ["0000-0002-1183-7290"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Rastegari", "ForeName": "Arezoo", "Initials": "A"}, {"Identifier": ["0000-0001-7326-5788"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Shams Ardekani", "ForeName": "Mohammad Reza", "Initials": "MR"}, {"Identifier": ["0000-0002-0212-7297"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}, {"Identifier": ["0000-0002-4053-6331"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Faculty of Land and Food Systems, University of British Columbia, Vancouver, British Columbia, Canada."}], "LastName": "Khanavi", "ForeName": "Mahnaz", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that there are no conflicts of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tublin J. M., Adelstein J. M., Del monte F., Combs C. K., Wold L. E. Getting to the heart of alzheimer disease. Circulation Research. 2019;124(1):142\u2013149. doi: 10.1161/circresaha.118.313563.", "ArticleIdList": ["10.1161/circresaha.118.313563", "PMC6319653", "30605407"]}, {"Citation": "Mount C., Downton C. Alzheimer disease: progress or profit? Nature Medicine. 2006;12(7):780\u2013784. doi: 10.1038/nm0706-780.", "ArticleIdList": ["10.1038/nm0706-780", "16829947"]}, {"Citation": "Becker R. E., Greig N. H., Giacobini E., Schneider L. S., Ferrucci L. A new roadmap for drug development for Alzheimer\u2019s disease. Nature Reviews Drug Discovery. 2014;13(2):156. doi: 10.1038/nrd3842-c2.", "ArticleIdList": ["10.1038/nrd3842-c2", "PMC4668586", "24362362"]}, {"Citation": "Kalaria R. N., Maestre G. E., Arizaga R., et al. Alzheimer\u2019s disease and vascular dementia in developing countries: prevalence, management, and risk factors. The Lancet Neurology. 2008;7(9):812\u2013826. doi: 10.1016/s1474-4422(08)70169-8.", "ArticleIdList": ["10.1016/s1474-4422(08)70169-8", "PMC2860610", "18667359"]}, {"Citation": "Cheng Y.-J., Lin C.-H., Lane H.-Y. Involvement of cholinergic, adrenergic, and glutamatergic network modulation with cognitive dysfunction in alzheimer\u2019 disease. International Journal of Molecular Sciences. 2021;22(5):p. 2283. doi: 10.3390/ijms22052283.", "ArticleIdList": ["10.3390/ijms22052283", "PMC7956475", "33668976"]}, {"Citation": "Ohm D. T., Fought A. J., Martersteck A., et al. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease. Brain Pathology. 2021;31(1):189\u2013204. doi: 10.1111/bpa.12902.", "ArticleIdList": ["10.1111/bpa.12902", "PMC7855834", "33010092"]}, {"Citation": "Picone P., Nuzzo D., Giacomazza D., Di carlo M. \u03b2-Amyloid peptide: the cell compartment multi-faceted interaction in alzheimer\u2019s disease. Neurotoxicity Research. 2020;37(2):250\u2013263. doi: 10.1007/s12640-019-00116-9.", "ArticleIdList": ["10.1007/s12640-019-00116-9", "31811589"]}, {"Citation": "Gomes L. M. F., Bataglioli J. C., Storr T. Metal complexes that bind to the amyloid-\u03b2 peptide of relevance to Alzheimer\u2019s disease. Coordination Chemistry Reviews. 2020;412 doi: 10.1016/j.ccr.2020.213255.213255", "ArticleIdList": ["10.1016/j.ccr.2020.213255"]}, {"Citation": "Cano-Abad M. F., Villarroya M., Garc\u00eda A. G., Gabilan N. H., L\u00f3pez M. G. Calcium entry through L-type calcium channels causes mitochondrial disruption and chromaffin cell death. Journal of Biological Chemistry. 2001;276(43):39695\u201339704. doi: 10.1074/jbc.m102334200.", "ArticleIdList": ["10.1074/jbc.m102334200", "11500491"]}, {"Citation": "Bhat A. H., Dar K. B., Anees S., et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomedicine & Pharmacotherapy. 2015;74:101\u2013110. doi: 10.1016/j.biopha.2015.07.025.", "ArticleIdList": ["10.1016/j.biopha.2015.07.025", "26349970"]}, {"Citation": "Francis P. T., Palmer A. M., Snape M., Wilcock G. K. The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. Journal of Neurology, Neurosurgery & Psychiatry. 1999;66(2):137\u2013147. doi: 10.1136/jnnp.66.2.137.", "ArticleIdList": ["10.1136/jnnp.66.2.137", "PMC1736202", "10071091"]}, {"Citation": "Chatonnet A., Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochemical Journal. 1989;260(3):625\u2013634. doi: 10.1042/bj2600625.", "ArticleIdList": ["10.1042/bj2600625", "PMC1138724", "2669736"]}, {"Citation": "Massouli\u00e9 J., Pezzementi L., Bon S., Krejci E., Vallette F.-M. Molecular and cellular biology of cholinesterases. Progress in Neurobiology. 1993;41(1):31\u201391. doi: 10.1016/0301-0082(93)90040-y.", "ArticleIdList": ["10.1016/0301-0082(93)90040-y", "8321908"]}, {"Citation": "Anand P., Singh B. A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Archives of Pharmacal Research. 2013;36(4):375\u2013399. doi: 10.1007/s12272-013-0036-3.", "ArticleIdList": ["10.1007/s12272-013-0036-3", "23435942"]}, {"Citation": "Camara V. S., Soares A. J., Biscussi B., Murray A. P., Ceschi M. A. Expedient microwave-assisted synthesis of bis (n)-lophine analogues as selective butyrylcholinesterase inhibitors: cytotoxicity evaluation and molecular modelling. Journal of the Brazilian Chemical Society. 2021;32(6):1173\u20131185. doi: 10.21577/0103-5053.20210018.", "ArticleIdList": ["10.21577/0103-5053.20210018"]}, {"Citation": "Chen V. P., Gao Y., Geng L., Parks R. J., Pang Y.-P., Brimijoin S. Plasma butyrylcholinesterase regulates ghrelin to control aggression. Proceedings of the National Academy of Sciences. 2015;112(7):2251\u20132256. doi: 10.1073/pnas.1421536112.", "ArticleIdList": ["10.1073/pnas.1421536112", "PMC4343161", "25646463"]}, {"Citation": "Tasker A., Perry E. K., Ballard C. G. Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment. Expert Review of Neurotherapeutics. 2005;5(1):101\u2013106. doi: 10.1586/14737175.5.1.101.", "ArticleIdList": ["10.1586/14737175.5.1.101", "15853480"]}, {"Citation": "Bortolami M., Rocco D., Messore A., et al. Acetylcholinesterase inhibitors for the treatment of Alzheimer\u2019s disease-a patent review (2016-present) Expert Opinion on Therapeutic Patents. 2021;31(5):399\u2013420. doi: 10.1080/13543776.2021.1874344.", "ArticleIdList": ["10.1080/13543776.2021.1874344", "33428491"]}, {"Citation": "Abubakar S., Khor B.-K., Khaw K.-Y., Murugaiyah V., Chan K.-L. Cholinesterase inhibitory potential of Dillenia suffruticosa chemical constituents and protective effect against A\u03b2\u2212induced toxicity in transgenic Caenorhabditis elegans model. Phytomedicine Plus. 2021;1(1) doi: 10.1016/j.phyplu.2021.100022.100022", "ArticleIdList": ["10.1016/j.phyplu.2021.100022"]}, {"Citation": "Garc\u00eda-Ayll\u00f3n M.-S., Small D. H., Avila J., Saez-Valero J. Revisiting the role of acetylcholinesterase in Alzheimer\u2019s disease: cross-talk with P-tau and \u03b2-amyloid. Frontiers in Molecular Neuroscience. 2011;4:p. 22. doi: 10.3389/fnmol.2011.00022.", "ArticleIdList": ["10.3389/fnmol.2011.00022", "PMC3171929", "21949503"]}, {"Citation": "Cummings J. L., Tong G., Ballard C. Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options. Journal of Alzheimer\u2019s Disease. 2019;67(3):779\u2013794. doi: 10.3233/jad-180766.", "ArticleIdList": ["10.3233/jad-180766", "PMC6398562", "30689575"]}, {"Citation": "Balaei-Kahnamoei M., Bozorgi M., Khanavi M., et al. Study of henna in Persian medicine and new studies. Journal of Islamic Iranian Traditional Medicine. 2019;10(1):57\u201369."}, {"Citation": "Elmanama A. A., Alyazji A. A., Abu-Gheneima N. Antibacterial, antifungal and synergistic effect of Lawsonia inermis, Punica granatum and Hibiscus sabdariffa. Annals of Alquds Medicine. 2011;7:33\u201341."}, {"Citation": "Chengaiah B., Rao K. M., Kumar K. M., Alagusundaram M., Chetty C. M. Medicinal importance of natural dyes-a review. International Journal of PharmTech Research. 2010;2(1):144\u2013154."}, {"Citation": "Ajitha B., Reddy Y. A. K., Reddy P. S., Suneetha Y., Jeon H.-J., Ahn C. W. Instant biosynthesis of silver nanoparticles using Lawsonia inermis leaf extract: innate catalytic, antimicrobial and antioxidant activities. Journal of Molecular Liquids. 2016;219:474\u2013481. doi: 10.1016/j.molliq.2016.03.041.", "ArticleIdList": ["10.1016/j.molliq.2016.03.041"]}, {"Citation": "Tripathi R. D., Srivastava H. S., Dixit S. N. A fungitoxic principle from the leaves of Lawsonia inermis Lam. Experientia. 1978;34(1):51\u201352. doi: 10.1007/bf01921895.", "ArticleIdList": ["10.1007/bf01921895", "620734"]}, {"Citation": "Khorasani M. A. Makhzan Al Advieh. Tehran, Iran: Bavardaran Press Research institute for Islamic and Complementary Medicine, Iran University of Medical Sciences; 2001."}, {"Citation": "Omidpanah S., Vahedi-Mazdabadi Y., Manayi A., et al. Phytochemical investigation and anticholinesterase activity of ethyl acetate fraction of myristica fragrans houtt. seeds. Natural Product Research. 2020:1\u20137. doi: 10.1080/14786419.2020.1788555.", "ArticleIdList": ["10.1080/14786419.2020.1788555", "32640862"]}, {"Citation": "Saeedi M., Vahedi-Mazdabadi Y., Rastegari A., Soleimani M., Eftekhari M., Akbarzadeh T. Evaluation of asarum europaeum L. Rhizome for the biological activities related to Alzheimer\u2019s disease. Research Journal of Pharmacognosy. 2020;7(3):25\u201333. doi: 10.22127/RJP.2020.223143.1565.", "ArticleIdList": ["10.22127/RJP.2020.223143.1565"]}, {"Citation": "Rahmani-Nezhad S., Dianat S., Fooladi Z., et al. Investigation of polysaccharide extracts from Iranian and French strains of Agaricus subrufescens against enzymes involved in Alzheimer\u2019s disease. Bolet\u00edn Latinoamericano y del Caribe de Plantas Medicinales y Arom\u00e1ticas. 2019;18(6):544\u2013554. doi: 10.35588/blacpma.19.18.5.", "ArticleIdList": ["10.35588/blacpma.19.18.5"]}, {"Citation": "Vahedi-Mazdabadi Y., Karimpour-Razkenari E., Akbarzadeh T., et al. Anti-cholinesterase and neuroprotective activities of sweet and bitter apricot kernels (prunus armeniaca L.) Iranian Journal of Pharmaceutical Research: IJPR. 2020;19(4):p. 216. doi: 10.22037/ijpr.2019.15514.13139.", "ArticleIdList": ["10.22037/ijpr.2019.15514.13139", "PMC8019877", "33841537"]}, {"Citation": "Bozorgi M., Najafi Z., Omidpanah S., et al. Investigation of anti-Alzheimer's activity of aqueous extract of areca nuts (Areca catechu L.): in vitro and in vivo studies. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas. 2021;20(4):406\u2013415. doi: 10.37360/blacpma.21.20.4.30.", "ArticleIdList": ["10.37360/blacpma.21.20.4.30"]}, {"Citation": "Ellman G. L., Courtney K. D., Andres V., Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology. 1961;7(2):88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Rastegari A., Nadri H., Mahdavi M., et al. Design, synthesis and anti-Alzheimer\u2019s activity of novel 1, 2, 3-triazole-chromenone carboxamide derivatives. Bioorganic Chemistry. 2019;83:391\u2013401. doi: 10.1016/j.bioorg.2018.10.065.", "ArticleIdList": ["10.1016/j.bioorg.2018.10.065", "30412794"]}, {"Citation": "Orhan I. E., Senol F. S., Shekfeh S., Skalicka-Wozniak K., Banoglu E. Pteryxin-a promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea. Food and Chemical Toxicology. 2017;109:970\u2013974. doi: 10.1016/j.fct.2017.03.016.", "ArticleIdList": ["10.1016/j.fct.2017.03.016", "28286309"]}, {"Citation": "Balaei-Kahnamoei M., Eftekhari M., Shams-Ardekani M. R., et al. Phytochemical constituents and biological activities of Salvia macrosiphon Boiss. BMC Chemistry. 2021;15(1):1\u20137. doi: 10.1186/s13065-020-00728-9.", "ArticleIdList": ["10.1186/s13065-020-00728-9", "PMC7814726", "33468228"]}, {"Citation": "Jo Y., Suh J., Shin M. H., Jung J. H., Im K. S. Jacaranone and related compounds from the fresh fruits ofTernstroemia japonica and their antioxidative activity. Archives of Pharmacal Research. 2005;28(8):885\u2013888. doi: 10.1007/bf02973871.", "ArticleIdList": ["10.1007/bf02973871", "16178411"]}, {"Citation": "Liao C.-R., Kuo Y.-H., Ho Y.-L., et al. Studies on cytotoxic constituents from the leaves of Elaeagnus oldhamii maxim. in non-small cell lung cancer A549 cells. Molecules. 2014;19(7):9515\u20139534. doi: 10.3390/molecules19079515.", "ArticleIdList": ["10.3390/molecules19079515", "PMC6271351", "25000464"]}, {"Citation": "Sholichin M., Yamasaki K., Kasai R., Tanaka O. ^C nuclear magnetic resonance of lupane-type triterpenes, lupeol, betulin and betulinic acid. Chemical and Pharmaceutical Bulletin. 1980;28(3):1006\u20131008. doi: 10.1248/cpb.28.1006.", "ArticleIdList": ["10.1248/cpb.28.1006"]}, {"Citation": "Samarakoon S. R., Ediriweera M. K., Wijayabandara L., et al. Isolation of cytotoxic triterpenes from the mangrove plant, Scyphiphora hydrophyllacea C.F. Gaertn (Rubiaceae) Tropical Journal of Pharmaceutical Research. 2018;17(3):475\u2013481. doi: 10.4314/tjpr.v17i3.13.", "ArticleIdList": ["10.4314/tjpr.v17i3.13"]}, {"Citation": "Pent\u00f3n-Rol G., Cervantes-Llanos M. Report on the symposium \u201cmolecular mechanisms involved in neurodegeneration\u201d. Behavioral Sciences. 2018;8(1):p. 16. doi: 10.3390/bs8010016.", "ArticleIdList": ["10.3390/bs8010016", "PMC5791034", "29346273"]}, {"Citation": "Saeedi M., Rastegari A., Hariri R., et al. Design and synthesis of novel arylisoxazole\u2010chromenone carboxamides: investigation of biological activities associated with Alzheimer\u2019s disease. Chemistry & Biodiversity. 2020;17(5) doi: 10.1002/cbdv.201900746.e1900746", "ArticleIdList": ["10.1002/cbdv.201900746", "32154628"]}, {"Citation": "Jing L., Wu G., Kang D., et al. Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors. Drug Discovery Today. 2019;24(2):629\u2013635. doi: 10.1016/j.drudis.2018.11.012.", "ArticleIdList": ["10.1016/j.drudis.2018.11.012", "30503804"]}, {"Citation": "Lee I., Ahn B., Choi J., Hattori M., Min B., Bae K. Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum. Bioorganic & Medicinal Chemistry Letters. 2011;21(21):6603\u20136607. doi: 10.1016/j.bmcl.2011.04.042.", "ArticleIdList": ["10.1016/j.bmcl.2011.04.042", "21924611"]}, {"Citation": "Ahmed F., Ghalib R., Sasikala P., Mueen Ahmed K. Cholinesterase inhibitors from botanicals. Pharmacognosy Reviews. 2013;7(14):p. 121. doi: 10.4103/0973-7847.120511.", "ArticleIdList": ["10.4103/0973-7847.120511", "PMC3841990", "24347920"]}, {"Citation": "Liu B., Yang L., Xu Y.-K., Liao S.-G., Luo H.-R., Na Z. Two new triterpenoids from Gelsemium elegans and Aglaia odorata. Natural Product Communications. 2013;8(10) doi: 10.1177/1934578x1300801008.1934578X1300801008", "ArticleIdList": ["10.1177/1934578x1300801008", "24354178"]}, {"Citation": "Amat-ur-Rasool H., Symes F., Tooth D., et al. Potential nutraceutical properties of leaves from several commonly cultivated plants. Biomolecules. 2020;10(11):p. 1556. doi: 10.3390/biom10111556.", "ArticleIdList": ["10.3390/biom10111556", "PMC7698063", "33203123"]}, {"Citation": "Rajesh V., Riju T., Venkatesh S., Babu G. Memory enhancing activity of Lawsonia inermis Linn. leaves against scopolamine induced memory impairment in Swiss albino mice. Oriental Pharmacy and Experimental Medicine. 2017;17(2):127\u2013142. doi: 10.1007/s13596-017-0268-8.", "ArticleIdList": ["10.1007/s13596-017-0268-8"]}, {"Citation": "Mir N. T., Saleem U., Anwar F., et al. Lawsonia Inermis markedly improves cognitive functions in animal models and modulate oxidative stress markers in the brain. Medicina. 2019;55(5):p. 192. doi: 10.3390/medicina55050192.", "ArticleIdList": ["10.3390/medicina55050192", "PMC6571555", "31121979"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "5", "Day": "7"}, {"Year": "2021", "Month": "6", "Day": "12"}, {"Year": "2021", "Month": "7", "Day": "1"}, {"Year": "2021", "Month": "8", "Day": "2", "Hour": "5", "Minute": "57"}, {"Year": "2021", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "7", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["34335830", "PMC8313326", "10.1155/2021/5965061"]}}], "PubmedBookArticle": []}